Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAB Foods Regulatory News (ABF)

Share Price Information for AB Foods (ABF)

Share Price is delayed by 15 minutes
Get Live Data
1,863.00    -1.00 (-0.05%)
Bid:
1,865.50
Ask:
1,866.50
Spread: 1.00 (0.054%)
Market Cap: £13.04b
ABF Live PriceLast checked at - London Stock Exchange

Intraday AB Foods Share Chart

Share Repurchase Programme

9 Nov 2022 07:00

RNS Number : 8069F
Associated British Foods PLC
09 November 2022
 

Associated British Foods plc

9 November 2022

 

Associated British Foods plc share repurchase programme

 

Further to its announcement on 8 November 2022, Associated British Foods plc (the "Company") announces that it is to commence the first tranche of its up to £500 million share buyback programme (the "Programme").

 

The first tranche of the Programme will be in the sum of up to £250 million and will commence today, 9 November 2022, and it is anticipated to end on or before 28 April 2023 (the "Engagement Period").

 

To execute the first tranche of this buyback, the Company has entered into an irrevocable and non-discretionary arrangement with Barclays Capital Securities Limited ("Barclays") to buy back up to £250 million of its ordinary shares (the "Engagement").

 

Under this arrangement, Barclays will act as principal and will make decisions independently from the Company under the Engagement. Barclays will carry out the arrangement through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. Purchases may continue during any closed period to which the Company is subject during the Engagement Period.

 

The sole purpose of the share buyback is to reduce the capital of the Company. All ordinary shares repurchased as part of this arrangement will be cancelled.

 

Share purchases will take place in open market transactions and be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and may be made from time to time depending on market conditions, share price, trading volume and other factors.

 

Any purchases of ordinary shares by the Company in relation to this announcement will be effected within certain pre-set parameters and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase ordinary shares granted by its shareholders (at the AGM in 2021, shareholders gave the Company authority to purchase a maximum of 79,167,418 ordinary shares), the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018) and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

The Company intends to enter into arrangements to commence a second tranche of the Programme in the sum of £250 million in due course.

 

 

Further enquiries:

+44 (0)20 7399 6545

John Bason, Finance Director

Chris Barrie, Corporate Affairs Director

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKLBBLFLEFBB
Date   Source Headline
3rd Mar 20265:11 pmRNSTransaction in Own Shares
2nd Mar 20265:31 pmRNSTransaction in Own Shares
27th Feb 20265:36 pmRNSTransaction in Own Shares
27th Feb 20264:51 pmRNSTotal Voting Rights
26th Feb 20265:31 pmRNSTransaction in Own Shares
25th Feb 20265:34 pmRNSTransaction in Own Shares
25th Feb 20267:00 amRNSShare repurchase programme
30th Jan 20265:49 pmRNSTransaction in Own Shares
30th Jan 20265:03 pmRNSTotal Voting Rights
29th Jan 20265:25 pmRNSTransaction in Own Shares
28th Jan 20265:15 pmRNSTransaction in Own Shares
27th Jan 20265:52 pmRNSTransaction in Own Shares
26th Jan 20265:33 pmRNSTransaction in Own Shares
23rd Jan 20265:13 pmRNSTransaction in Own Shares
22nd Jan 20265:17 pmRNSTransaction in Own Shares
22nd Jan 20262:59 pmRNSDirector Declaration
22nd Jan 20267:00 amRNSABF Trading Update
21st Jan 20265:28 pmRNSTransaction in Own Shares
20th Jan 20265:26 pmRNSTransaction in Own Shares
19th Jan 20265:14 pmRNSTransaction in Own Shares
16th Jan 20265:20 pmRNSTransaction in Own Shares
15th Jan 20265:06 pmRNSTransaction in Own Shares
14th Jan 20265:16 pmRNSTransaction in Own Shares
13th Jan 20265:17 pmRNSTransaction in Own Shares
12th Jan 20265:20 pmRNSTransaction in Own Shares
9th Jan 20265:32 pmRNSTransaction in Own Shares
8th Jan 20265:28 pmRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTrading Update
7th Jan 20265:12 pmRNSTransaction in Own Shares
5th Jan 20265:29 pmRNSTransaction in Own Shares
5th Jan 202611:00 amRNSStandard form for notification of major holdings
2nd Jan 20265:44 pmRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20251:09 pmRNSTransaction in Own Shares
31st Dec 20251:09 pmRNSTransaction in Own Shares
30th Dec 20255:12 pmRNSTransaction in Own Shares
30th Dec 20255:12 pmRNSTransaction in Own Shares
29th Dec 20255:25 pmRNSTransaction in Own Shares
29th Dec 20255:25 pmRNSTransaction in Own Shares
24th Dec 20251:16 pmRNSTransaction in Own Shares
24th Dec 20251:16 pmRNSTransaction in Own Shares
23rd Dec 20255:16 pmRNSTransaction in Own Shares
23rd Dec 20255:16 pmRNSTransaction in Own Shares
22nd Dec 20255:13 pmRNSTransaction in Own Shares
22nd Dec 20255:13 pmRNSTransaction in Own Shares
19th Dec 20255:20 pmRNSTransaction in Own Shares
19th Dec 20255:20 pmRNSTransaction in Own Shares
18th Dec 20255:04 pmRNSTransaction in Own Shares
18th Dec 20255:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.